5 news items
Weight Loss Drug Market To Rocket To $130B By 2030 With Eli Lilly, Novo Nordisk In Lead: Goldman Sachs
LLY
NVO
30 May 24
and Novo Nordisk, will likely sustain their dominant share and market leadership.
The analyst expects the players to retain ~ 80% share
Lilly, UNICEF expand support to help millions of young people at risk of noncommunicable diseases
LLY
29 May 24
ensuring healthy lives and promoting well-being for all, which is in line with the United Nations Sustainable Development Goals
What Are Pricing Strategies for Ozempic And Wegovy With Potential Medicare Coverage Expansion? Senate Committee Questions Novo Nordisk
LLY
NVO
24 Apr 24
emphasized the necessity of reducing prices to ensure accessibility for consumers and sustainability for governments.
Senator Sanders penned
Investment Opportunities in Biotech Amidst Federal Rate Uncertainties (ATNM)
ABBV
ATNM
AZN
22 Apr 24
of sustained outperformance, especially if interest rates trend downwards coupled with continuous innovation and active M
Navigating Interest Rate Speculations and M&A Trends with a Spotlight on Actinium Pharmaceuticals (ATNM)
ATNM
AZN
BMY
18 Apr 24
and strategic industry movements.
Morgan Stanley predicts sustained outperformance for biotech stocks, particularly
- Prev
- 1
- Next